Hydration Pharmaceuticals Focuses on U.S. Growth with Asset Sale

Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.

Don't Miss our Black Friday Offers:

Hydration Pharmaceuticals Co. Ltd. has strengthened its financial position by divesting non-U.S. assets for $9.5 million, allowing the company to pay off debt and focus on its U.S. operations. The strategic shift includes streamlining operations and emphasizing ecommerce sales, particularly the successful Liver Detox product, which has significantly boosted sales and profitability. This move is expected to continue driving growth and improving EBITDA in the coming quarters.

For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.